Corium International, Inc. is a privately-owned company engaged in the research, development and manufacture of advanced transdermal drug delivery technologies and products. Through the combination of its proprietary delivery technologies and its development and manufacturing expertise, Corium is developing a range of novel active and passive transdermal products. Corium’s self-funded product pipeline is based on high-value, FDA approved drugs reformulated with Corium’s proprietary systems. Corium also has several partner-funded products under development with small, medium and large pharmaceutical companies.
 
Corium has complete technical capability ranging from concept, formulation, prototyping, clinical supply manufacture and full scale manufacturing. Corium has proven processing experience with diverse, highly specialized processes including custom designed liquid mix systems, custom designed continuous and semicontinuous extrusion, solvent and water based coatings, specialized intermittent and lamination/die cut/pouching equipment.

(616) 656-4563
www.coriumgroup.com